InvestorsHub Logo
Followers 242
Posts 12315
Boards Moderated 0
Alias Born 08/14/2003

Re: biosectinvestor post# 538783

Friday, 11/25/2022 8:10:23 PM

Friday, November 25, 2022 8:10:23 PM

Post# of 701081
It's very possible that an equity partnership could require a special meeting in the future which authorized both the partnership and the additional shares that may be needed to consummate it. Again, I don't believe the company would have any problem getting the authorization from shareholders.

If an equity partnership is in the works at say $10 a share for talking purposes, I believe we'd be well served if half the shares were new, paying the company, and half were tindered by shareholders. Let's say we had 1.5 billion shares outstanding at the time, if the partner wanted 500M shares, the company would receive $2.5 billion and the OS would go to 1.75 billion shares. That ought to be sufficient funding for the immediate future to initiate a number of trials and build sufficient support for worldwide sales of DCVax-L.

The numbers suggested above are only intended to illustrate how I'm suggesting it could be done. I believe that LP is looking for over $10 a share in such a partnership, but perhaps less than the $20+ she's thought to be looking at as the minimum for a buyout.

Gary
Bullish
Bullish
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News